Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients

Yuh Min Chen, Wen Kuang Yang, Chou Chik Ting, Wen Ying Tsai, Den Mei Yang, Jacqueline Whang-Peng, Reury Perng Perng

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Study objective: Our previous report demonstrated that there was impairment of local cellular immunity with elevated interleukin-10 (IL-10) and undetectable IL-12 in neoplastic pleural effusion. These findings suggest that the local immune reactions favor the T-helper type 2 (Th2) pathway instead of Th1 pathway. The present study was designed to examine whether local cellular immunity could be manipulated by IL-2 and/or IL-12 treatment, and to determine their effect on the helper T-cell pathways and the cytolytic activity of the effusion-associated lymphocytes (EALs). Design: Using malignant pleural effusions obtained from four patients suffering from adenocarcinoma of lung, we separated the tumor cells from the EALs with Ficol-Hypaque centrifugation, followed by Percoll density centrifugation. To test whether the cytolytic function of lymphocytes could be enhanced by culturing with IL-2 and/or IL-12, lymphocytes were incubated with recombinant IL-2 with/without IL-12 for 6 days. Following this, the tumoricidal activity was assessed in an overnight chromium-release assay. Autologous tumor cells for measuring specific antitumor activity, Daudi cells susceptible to lymphokine-activated killer cells, and NK-susceptible K562 cells were used as target cells. Measurements and results: After treatment in vitro with IL-2, IL-12, or IL-2 plus IL-12, the Th pathway shifted from Th2 to Th1 type (increased χ-interferon production). To further study the effect of cytokine treatment on the cytolytic activity of EALs, it was found that after 6-day, culturing, the EALs rafted to kill any of the three tumor targets, whereas the 6-day cultured peripheral blood lymphocytes (PBLs) gave low level of cytotoxicity against all three tumor targets. Stimulation with IL-2 alone partially restored the immunocompetence of EALs to kill the tumor targets. Stimulation with IL-12 alone showed no significant effect on their cytolytic activity. However, IL-12 synergized with IL-2 to increase the cytolytic activity of EALs and PBLs against autologous tumor targets. This synergistic effect was not found for Daudi cells and K562 cells. Conclusions: These results suggest that EALs activated with IL-12 in the presence of a low concentration of IL-2, which converted the EALs from Th2 pathway to Th1 pathway, could bean alternative source of antitumor effectors for adoptive immunotherapy of cancer.

Original languageEnglish
Pages (from-to)960-966
Number of pages7
JournalChest
Volume112
Issue number4
DOIs
Publication statusPublished - Jan 1 1997
Externally publishedYes

Fingerprint

Interleukin-12
Helper-Inducer T-Lymphocytes
Interleukin-10
Interleukin-2
Lung Neoplasms
Lymphocytes
Neoplasms
K562 Cells
Centrifugation
Cellular Immunity
Malignant Pleural Effusion
Diatrizoate
Adoptive Immunotherapy
Immunocompetence
Lymphokine-Activated Killer Cells
Chromium
Pleural Effusion
Interferons
Interleukin-6
Therapeutics

Keywords

  • Interleukin-2 (IL-2)
  • γ-Interferon (IFN-γ)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients. / Chen, Yuh Min; Yang, Wen Kuang; Ting, Chou Chik; Tsai, Wen Ying; Yang, Den Mei; Whang-Peng, Jacqueline; Perng, Reury Perng.

In: Chest, Vol. 112, No. 4, 01.01.1997, p. 960-966.

Research output: Contribution to journalArticle

Chen, Yuh Min ; Yang, Wen Kuang ; Ting, Chou Chik ; Tsai, Wen Ying ; Yang, Den Mei ; Whang-Peng, Jacqueline ; Perng, Reury Perng. / Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients. In: Chest. 1997 ; Vol. 112, No. 4. pp. 960-966.
@article{53f24e2be44c4226bfadd4547e497dd6,
title = "Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients",
abstract = "Study objective: Our previous report demonstrated that there was impairment of local cellular immunity with elevated interleukin-10 (IL-10) and undetectable IL-12 in neoplastic pleural effusion. These findings suggest that the local immune reactions favor the T-helper type 2 (Th2) pathway instead of Th1 pathway. The present study was designed to examine whether local cellular immunity could be manipulated by IL-2 and/or IL-12 treatment, and to determine their effect on the helper T-cell pathways and the cytolytic activity of the effusion-associated lymphocytes (EALs). Design: Using malignant pleural effusions obtained from four patients suffering from adenocarcinoma of lung, we separated the tumor cells from the EALs with Ficol-Hypaque centrifugation, followed by Percoll density centrifugation. To test whether the cytolytic function of lymphocytes could be enhanced by culturing with IL-2 and/or IL-12, lymphocytes were incubated with recombinant IL-2 with/without IL-12 for 6 days. Following this, the tumoricidal activity was assessed in an overnight chromium-release assay. Autologous tumor cells for measuring specific antitumor activity, Daudi cells susceptible to lymphokine-activated killer cells, and NK-susceptible K562 cells were used as target cells. Measurements and results: After treatment in vitro with IL-2, IL-12, or IL-2 plus IL-12, the Th pathway shifted from Th2 to Th1 type (increased χ-interferon production). To further study the effect of cytokine treatment on the cytolytic activity of EALs, it was found that after 6-day, culturing, the EALs rafted to kill any of the three tumor targets, whereas the 6-day cultured peripheral blood lymphocytes (PBLs) gave low level of cytotoxicity against all three tumor targets. Stimulation with IL-2 alone partially restored the immunocompetence of EALs to kill the tumor targets. Stimulation with IL-12 alone showed no significant effect on their cytolytic activity. However, IL-12 synergized with IL-2 to increase the cytolytic activity of EALs and PBLs against autologous tumor targets. This synergistic effect was not found for Daudi cells and K562 cells. Conclusions: These results suggest that EALs activated with IL-12 in the presence of a low concentration of IL-2, which converted the EALs from Th2 pathway to Th1 pathway, could bean alternative source of antitumor effectors for adoptive immunotherapy of cancer.",
keywords = "Interleukin-2 (IL-2), γ-Interferon (IFN-γ)",
author = "Chen, {Yuh Min} and Yang, {Wen Kuang} and Ting, {Chou Chik} and Tsai, {Wen Ying} and Yang, {Den Mei} and Jacqueline Whang-Peng and Perng, {Reury Perng}",
year = "1997",
month = "1",
day = "1",
doi = "10.1378/chest.112.4.960",
language = "English",
volume = "112",
pages = "960--966",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients

AU - Chen, Yuh Min

AU - Yang, Wen Kuang

AU - Ting, Chou Chik

AU - Tsai, Wen Ying

AU - Yang, Den Mei

AU - Whang-Peng, Jacqueline

AU - Perng, Reury Perng

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Study objective: Our previous report demonstrated that there was impairment of local cellular immunity with elevated interleukin-10 (IL-10) and undetectable IL-12 in neoplastic pleural effusion. These findings suggest that the local immune reactions favor the T-helper type 2 (Th2) pathway instead of Th1 pathway. The present study was designed to examine whether local cellular immunity could be manipulated by IL-2 and/or IL-12 treatment, and to determine their effect on the helper T-cell pathways and the cytolytic activity of the effusion-associated lymphocytes (EALs). Design: Using malignant pleural effusions obtained from four patients suffering from adenocarcinoma of lung, we separated the tumor cells from the EALs with Ficol-Hypaque centrifugation, followed by Percoll density centrifugation. To test whether the cytolytic function of lymphocytes could be enhanced by culturing with IL-2 and/or IL-12, lymphocytes were incubated with recombinant IL-2 with/without IL-12 for 6 days. Following this, the tumoricidal activity was assessed in an overnight chromium-release assay. Autologous tumor cells for measuring specific antitumor activity, Daudi cells susceptible to lymphokine-activated killer cells, and NK-susceptible K562 cells were used as target cells. Measurements and results: After treatment in vitro with IL-2, IL-12, or IL-2 plus IL-12, the Th pathway shifted from Th2 to Th1 type (increased χ-interferon production). To further study the effect of cytokine treatment on the cytolytic activity of EALs, it was found that after 6-day, culturing, the EALs rafted to kill any of the three tumor targets, whereas the 6-day cultured peripheral blood lymphocytes (PBLs) gave low level of cytotoxicity against all three tumor targets. Stimulation with IL-2 alone partially restored the immunocompetence of EALs to kill the tumor targets. Stimulation with IL-12 alone showed no significant effect on their cytolytic activity. However, IL-12 synergized with IL-2 to increase the cytolytic activity of EALs and PBLs against autologous tumor targets. This synergistic effect was not found for Daudi cells and K562 cells. Conclusions: These results suggest that EALs activated with IL-12 in the presence of a low concentration of IL-2, which converted the EALs from Th2 pathway to Th1 pathway, could bean alternative source of antitumor effectors for adoptive immunotherapy of cancer.

AB - Study objective: Our previous report demonstrated that there was impairment of local cellular immunity with elevated interleukin-10 (IL-10) and undetectable IL-12 in neoplastic pleural effusion. These findings suggest that the local immune reactions favor the T-helper type 2 (Th2) pathway instead of Th1 pathway. The present study was designed to examine whether local cellular immunity could be manipulated by IL-2 and/or IL-12 treatment, and to determine their effect on the helper T-cell pathways and the cytolytic activity of the effusion-associated lymphocytes (EALs). Design: Using malignant pleural effusions obtained from four patients suffering from adenocarcinoma of lung, we separated the tumor cells from the EALs with Ficol-Hypaque centrifugation, followed by Percoll density centrifugation. To test whether the cytolytic function of lymphocytes could be enhanced by culturing with IL-2 and/or IL-12, lymphocytes were incubated with recombinant IL-2 with/without IL-12 for 6 days. Following this, the tumoricidal activity was assessed in an overnight chromium-release assay. Autologous tumor cells for measuring specific antitumor activity, Daudi cells susceptible to lymphokine-activated killer cells, and NK-susceptible K562 cells were used as target cells. Measurements and results: After treatment in vitro with IL-2, IL-12, or IL-2 plus IL-12, the Th pathway shifted from Th2 to Th1 type (increased χ-interferon production). To further study the effect of cytokine treatment on the cytolytic activity of EALs, it was found that after 6-day, culturing, the EALs rafted to kill any of the three tumor targets, whereas the 6-day cultured peripheral blood lymphocytes (PBLs) gave low level of cytotoxicity against all three tumor targets. Stimulation with IL-2 alone partially restored the immunocompetence of EALs to kill the tumor targets. Stimulation with IL-12 alone showed no significant effect on their cytolytic activity. However, IL-12 synergized with IL-2 to increase the cytolytic activity of EALs and PBLs against autologous tumor targets. This synergistic effect was not found for Daudi cells and K562 cells. Conclusions: These results suggest that EALs activated with IL-12 in the presence of a low concentration of IL-2, which converted the EALs from Th2 pathway to Th1 pathway, could bean alternative source of antitumor effectors for adoptive immunotherapy of cancer.

KW - Interleukin-2 (IL-2)

KW - γ-Interferon (IFN-γ)

UR - http://www.scopus.com/inward/record.url?scp=0030821151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030821151&partnerID=8YFLogxK

U2 - 10.1378/chest.112.4.960

DO - 10.1378/chest.112.4.960

M3 - Article

C2 - 9377959

AN - SCOPUS:0030821151

VL - 112

SP - 960

EP - 966

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -